Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$18.7 - $23.07 $236,966 - $292,343
12,672 Added 2.03%
637,526 $12.8 Million
Q4 2022

Feb 14, 2023

SELL
$18.12 - $27.32 $3.93 Million - $5.92 Million
-216,617 Reduced 25.74%
624,854 $14.2 Million
Q3 2022

Nov 14, 2022

SELL
$16.98 - $25.54 $2.21 Million - $3.32 Million
-130,019 Reduced 13.38%
841,471 $15.8 Million
Q2 2022

Aug 15, 2022

BUY
$13.15 - $20.45 $920,500 - $1.43 Million
70,000 Added 7.76%
971,490 $18.1 Million
Q1 2022

May 16, 2022

BUY
$14.54 - $21.5 $3.28 Million - $4.84 Million
225,284 Added 33.32%
901,490 $16.3 Million
Q4 2021

Feb 14, 2022

SELL
$20.24 - $36.01 $13 Million - $23.2 Million
-643,307 Reduced 48.75%
676,206 $14 Million
Q3 2021

Nov 15, 2021

BUY
$26.01 - $38.22 $4.21 Million - $6.19 Million
162,000 Added 14.0%
1,319,513 $42.2 Million
Q2 2021

Aug 16, 2021

BUY
$29.97 - $37.17 $6.06 Million - $7.51 Million
202,089 Added 21.15%
1,157,513 $35.7 Million
Q1 2021

May 17, 2021

BUY
$29.24 - $42.03 $7.41 Million - $10.6 Million
253,374 Added 36.09%
955,424 $32.2 Million
Q4 2020

Feb 16, 2021

BUY
$35.35 - $50.67 $2.51 Million - $3.6 Million
70,990 Added 11.25%
702,050 $25.4 Million
Q3 2020

Nov 16, 2020

SELL
$35.98 - $47.66 $1.75 Million - $2.31 Million
-48,560 Reduced 7.15%
631,060 $23.2 Million
Q2 2020

Aug 14, 2020

BUY
$45.06 - $67.74 $8 Million - $12 Million
177,645 Added 35.39%
679,620 $30.6 Million
Q1 2020

May 15, 2020

BUY
$40.01 - $73.97 $4.2 Million - $7.77 Million
105,076 Added 26.47%
501,975 $23.8 Million
Q4 2019

Feb 14, 2020

BUY
$37.13 - $74.62 $211,641 - $425,334
5,700 Added 1.46%
396,899 $28.4 Million
Q3 2019

Nov 14, 2019

BUY
$39.36 - $76.8 $1.05 Million - $2.04 Million
26,603 Added 7.3%
391,199 $15.4 Million
Q1 2019

May 15, 2019

SELL
$27.39 - $68.41 $1.21 Million - $3.02 Million
-44,133 Reduced 10.8%
364,596 $21.7 Million
Q4 2018

Feb 14, 2019

BUY
$22.8 - $33.93 $9.32 Million - $13.9 Million
408,729 New
408,729 $11.8 Million

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Aquilo Capital Management, LLC Portfolio

Follow Aquilo Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquilo Capital Management, LLC with notifications on news.